Novavax, Inc. (NVAX): Price and Financial Metrics
Novavax, Inc. (NVAX)
Today's Latest Price: $4.35 USD
0.20 (-4.40%)
Updated Dec 6 12:00am
Add NVAX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NVAX Stock Summary
- Equity multiplier, or assets relative to shareholders' equity, comes in at -1.38 for Novavax Inc; that's greater than it is for only 4.8% of US stocks.
- Revenue growth over the past 12 months for Novavax Inc comes in at -45.9%, a number that bests only 3.85% of the US stocks we're tracking.
- In terms of volatility of its share price, NVAX is more volatile than 96.22% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Novavax Inc, a group of peers worth examining would be UMRX, INO, BCRX, MGNX, and PTI.
- Visit NVAX's SEC page to see the company's official filings. To visit the company's web site, go to www.novavax.com.
NVAX Daily Price Range
NVAX 52-Week Price Range
NVAX Stock Price Chart More Charts
NVAX Price/Volume Stats
| Current price | $4.35 |
| Prev. close | $4.55 |
| Day low | $4.33 |
| Day high | $4.62 |
| 50-day MA | $4.48 |
| 200-day MA | $7.16 |
| 52-week high | $51.60 |
| 52-week low | $3.54 |
| Volume | 1,326,600 |
| Avg. volume | 842,624 |
| Dividend yield | N/A |
| Market Cap | 115.61M |
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
Top Stories View All
Best & Worst Performing Stock Industries for December 6, 2019
Best & Worst Performing Small Cap Stocks for December 6, 2019
Best & Worst Performing Mid Cap Stocks for December 6, 2019
Best & Worst Performing Large Cap Stocks for December 6, 2019
Best & Worst Performing Mega Cap Stocks for December 6, 2019
View All Top Stories
Loading social stream, please wait...